Form D · Biotechnology
CurveBeam AI Ltd
Melbourne, C3 · CIK 0001953882
Offering snapshot reported Nov 22, 2022 · SEC filing
- Reported sold
- $255K Offering amount: $255K
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 31, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 22, 2022 | Initial | $255,409 | No comparison | 10 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $15K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-465543
The exercise price of the options is based on a formula and no definite exercise price can be currently provided.
Commission paid to Bell Potter Securities (US)LLC (6%).
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Bell Potter Securities (US) LLC | 289328 |
Source: Form D, filed Nov 22, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ura Phillip Stephen Auckland | Executive |
| Gregory Brown | Director |
| Waradana Malitha Hashan De Silva | Director |
| Robert Lilley | Director |
| David Seeman | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
Suite 5, Level 10 470 Collins Street
Melbourne, C3, VIC 3000
Melbourne, C3, VIC 3000